Equities
  • Price (EUR)104.00
  • Today's Change-0.32 / -0.31%
  • Shares traded50.00
  • 1 Year change-3.39%
  • Beta1.6610
Data delayed at least 15 minutes, as of Dec 05 2019 14:30 GMT.
More ▼

Key statistics

As of last trade, Alexion Pharmaceuticals Inc (AXPX:GER) traded at 104.00, 23.79% above the 52 week low of 84.01 set on Dec 27, 2018.
52-week range
Today
84.01Dec 27 2018125.29Apr 05 2019
Markit short selling activity
Low
Med
High
Open104.00
High104.00
Low104.00
Bid97.66
Offer98.32
Previous close104.32
Average volume93.82
Shares outstanding221.29m
Free float220.77m
P/E (TTM)19.13
Market cap25.55bn USD
EPS (TTM)6.04
USD
Data delayed at least 15 minutes, as of Dec 05 2019 14:30 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.